As shown in Supplementary Fig S4, MiaPaCa-1 cells (A MUC4 negative pancreatic cancer cells) were treated with indicated concentration of canertinib and analyzed for pHER2, total HER2, MUC4 and pFAK protein expression. The gene discussed is MUC4; the disease is pancreatic neoplasm.